Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Return on Invested Capital (ROIC) | 62.2% | 103.3% | (133.6%) | 111.0% | 114.0% | 92.5% | 62.3% | 50.7% | 27.0% | 20.3% | 69.0% | 94.8% | 73.4% | 22.6% | 21.1% | 16.5% | 13.5% | 10.0% | 11.8% | 13.3% |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Microsoft Corp's last 12-month Return on Invested Capital (ROIC) is 20.2%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Return on Invested Capital (ROIC) for Gilead Sciences, Inc. have been 14.1% over the past three years, and 13.3% over the past five years.
As of today, Gilead Sciences, Inc.'s Return on Invested Capital (ROIC) is 20.2%, which is higher than industry median of 13.6%. It indicates that Gilead Sciences, Inc.'s Return on Invested Capital (ROIC) is Good.